Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Long COVID patients may have hormonal imbalances linked to their symptoms.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Ayurveda's descriptions of genetic disorders align with modern genetic understanding.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Hormonal imbalances, especially high androgen levels and insulin resistance, are linked to worse acne in adult women.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Certain hormone treatments can improve acne and related conditions in women.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

AR gene not major factor in female hair loss; different from male hair loss.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Hormones and genes affect hair growth and male baldness.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.